Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

DSGN Design Therapeutics Inc

6,25

0,26 (4,34%)

21 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Design Therapeutics (NASDAQ:DSGN)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Design Therapeutics Charts.

Design Therapeutics (NASDAQ:DSGN)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Design Therapeutics Charts.

News Design Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 20 Dezember 2024 (3 Tage vor) • Edgar (US Regulatory)

Design Therapeutics to Participate in Multiple Upcoming Investor Conferences
Mittwoch 13 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 7 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Design Therapeutics Announces Third Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACTM Portfolio
Donnerstag 7 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
Dienstag 10 September 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Montag 12 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 9 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 5 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 5 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio
Montag 5 August 2024 (5 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Montag 17 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 17 Juni 2024 (6 Monate vor) • Edgar (US Regulatory)

Weitere Design Therapeutics Inc News-Artikel

Athens Water And Sewerag...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen